Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | GALR3 | O60755 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | CTPS1 | P17812 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14269795 | 0.83 | MIF (0.40) | MIFPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL2992084 | 0.82 | NPC1 (0.51) | POLBMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL1847472 | 0.82 | DAO (0.48) | MIFPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL6368901 | 0.82 | SLC6A3 (0.49) | POLBMEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL2789975 | 0.80 | MAPT (0.48) | MIFMEN1KMT2AALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL8634171 | 0.80 | DAO (0.47) | MIFPOLBMEN1KMT2AALDH1A1 | |
| SCHEMBL24210872 | 0.77 | MEN1 (0.38) | POLBMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL28263654 | 0.77 | SMN1; SMN2 (0.50) | MIFMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL8634167 | 0.77 | MIF (0.46) | MIFMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL11213610 | 0.76 | KMT2A (0.49) | MIFPOLBMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371425-A | Nitrogen-containing heterocyclic compound, preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-119330982-A | Azetidine compound and medical application thereof | 中国科学院上海药物研究所 | 2025-01-21 | — | — | CN | disclosed |
| CN-105283443-A | Heterocyclic derivatives and use thereof | C & C RES LAB | 2016-01-27 | — | — | CN | disclosed |
| EP-2324006-B1 | Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers | KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD (IN) | 2014-08-13 | — | — | EP | disclosed |
| US-8258119-B2 | Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers | Kasina Laila Innova Pharmaceuticals (IN) | 2012-09-04 | — | — | US | disclosed |
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2324006-A2 | ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS | Kasina Laila Innova Pharmaceuticals Private Ltd. (IN) | 2011-05-25 | — | — | EP | disclosed |
| WO-2010029577-A2 | ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS | GOKARAJU GANGA RAJU (IN) | 2010-03-18 | — | — | WO | disclosed |
| US-20100068178-A1 | ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS | LAILA NUTRACEUTICALS (IN) | 2010-03-18 | — | — | US | disclosed |
| CN-1849323-A | Thienopyrroles as antiviral agents | ANGELETTI P IST RICHERCHE BIO (IT) | 2006-10-18 | — | — | CN | disclosed |
| US-5310752-A | Distamycin A analogs; antitumor agents, viricides | FARMITALIA CARLO ERBA SPA (IT) | 1994-05-10 | — | — | US | disclosed |
| EP-0246868-B1 | SITE SPECIFIC ALKYLATING AGENTS | FARMITALIA CARLO ERBA S.r.l. (IT) | 1992-09-16 | — | — | EP | disclosed |
| US-5049579-A | Antitumor, viricides | FARMITALIA CARLO ERBA, S.R.L. (IT) | 1991-09-17 | — | — | US | disclosed |
| US-5017599-A | Antitumor, antiviral distamycin A analog | FARMITALIA CARLO ERBA, SPA (IT) | 1991-05-21 | — | — | US | disclosed |
| EP-0246868-A1 | Site specific alkylating agents | FARMITALIA CARLO ERBA S.r.l. (IT) | 1987-11-25 | — | — | EP | disclosed |
| US-4219482-A | Process for preparing thiophene and furan derivatives | LABAZ (FR) | 1980-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | KCNB1, KCNA5, KCNA7 | MIF 4865/4885POLB 1730/4885MEN1 3469/4885 |
| US-20100068178-A1 | ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS | BRAF, NRAS, TP53 | MIF 80/4885POLB 1250/4885MEN1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.